Opioid Peptides Don't Affect Low-Dose Dopamine Behavior in Mice
Mu, kappa, and delta opioid peptides injected into mouse brains did not alter behavioral responses to low-dose apomorphine, suggesting limited opioid-dopamine interaction at this level.
Quick Facts
What This Study Found
Receptor-selective opioid peptides (DAMGO, dynorphin A, DPLPE) had no effect on low-dose apomorphine-induced behavioral suppression.
Key Numbers
How They Did This
Researchers injected mice with low-dose apomorphine (0.03 mg/kg) to suppress behavior, then gave intracerebroventricular injections of receptor-selective opioid peptides. They measured circling, rearing, and locomotion.
Why This Research Matters
Understanding whether opioid and dopamine systems interact at the receptor level helps clarify how these two major brain signaling systems work together or independently.
The Bigger Picture
This negative result helps define the boundaries of opioid-dopamine interactions. Not every combination of these systems produces an effect, which is important for understanding drug interactions.
What This Study Doesn't Tell Us
Animal study in mice with direct brain injection. Tested only one dose of each opioid peptide. The lack of effect could reflect dose or timing issues rather than true absence of interaction.
Questions This Raises
- ?Would higher opioid doses or different dopamine doses produce an interaction?
- ?Are opioid-dopamine interactions only evident under specific conditions?
Trust & Context
- Key Stat:
- No interaction All three opioid receptor types failed to modify low-dose apomorphine behavior — a defined null zone for opioid-dopamine crosstalk
- Evidence Grade:
- Preliminary — animal study testing one dose of each peptide against one dose of apomorphine. Negative results may reflect narrow testing conditions.
- Study Age:
- Published in 1993 (33 years ago). Opioid-dopamine interactions have since been shown to be condition-dependent and dose-dependent.
- Original Title:
- Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mouse.
- Published In:
- Pharmacology, biochemistry, and behavior, 46(3), 587-91 (1993)
- Authors:
- Ukai, M, Toyoshi, T, Kameyama, T(3)
- Database ID:
- RPEP-00282
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why is a negative result important here?
Knowing where systems DON'T interact is as important as knowing where they do. This helps scientists and doctors predict when opioid drugs will or won't affect dopamine-related behaviors like movement and motivation.
Do opioids and dopamine ever interact?
Yes — under other conditions (higher doses, different brain states, chronic administration), opioid and dopamine systems do interact significantly. This study simply defines one condition where they don't.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00282APA
Ukai, M; Toyoshi, T; Kameyama, T. (1993). Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mouse.. Pharmacology, biochemistry, and behavior, 46(3), 587-91.
MLA
Ukai, M, et al. "Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mouse.." Pharmacology, 1993.
RethinkPeptides
RethinkPeptides Research Database. "Receptor-selective opioid peptides fail to affect behavioral..." RPEP-00282. Retrieved from https://rethinkpeptides.com/research/ukai-1993-receptorselective-opioid-peptides-fail
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.